BCCM
CEMI

Blue Clay Capital Management’s Chembio diagnostics, Inc. CEMI Stock Holding History

Blue Clay Capital Management’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$415K Buy
56,070
+9,970
+22% +$71.8K 0.47% 55
2016
Q2 		$378K Buy
+46,100
New +$359K 0.44% 58

Other funds holding CEMI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NJBEST
New Jersey Better Educational Savings Trust Trenton, New Jersey $62.2M AUM 2.58% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CPIM
Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Blue Clay Capital Management's CEMI Position: Q3 2016 in Review

Blue Clay Capital Management increased its Chembio diagnostics, Inc. (CEMI) stake by 22% in Q3 2016, buying an estimated $71.8K and bringing the position to 56,070 shares worth $415K. The position accounts for 0.47% of the portfolio, ranked #55.

Blue Clay Capital Management first reported a position in CEMI in Q2 2016 and has held it in 2 quarters since. 29 funds tracked by Wall St. Rank hold CEMI as of Q3 2016.

  • Blue Clay Capital Management held 56,070 shares of Chembio diagnostics, Inc. worth $415K as of Q3 2016.
  • Blue Clay Capital Management bought 9,970 Chembio diagnostics, Inc. shares in Q3 2016, an estimated $71.8K.
  • Chembio diagnostics, Inc. made up 0.47% of Blue Clay Capital Management's portfolio in Q3 2016, its #55 holding.
  • Blue Clay Capital Management first reported a position in Chembio diagnostics, Inc. in Q2 2016 and has held it in 2 quarters since.
  • 29 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q3 2016.

Based on Blue Clay Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.